ReviewTranslational andrology and urology2017
Etiologic classification, evaluation, and management of hematospermia.
Review in Translational andrology and urology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 31 citations in OpenAlex.
- Review
- Robotic unilateral seminal vesiculectomy for chronic hematospermia.Urology case reports · 2025Article
- Efficacy of various surgical approaches in treating hematospermia using transurethral seminal vesiculoscopy.BMC surgery · 2023Article
- Altered microbiota profile in seminal vesicles of men presenting with refractory hematospermia.Molecular biology reports · 2023Article
- Novel Algorithm for the Management of Hematospermia.Turkish journal of urology · 2022Article
- Detection rates of urogenital cancers and benign pathology in men presenting with hematospermia.Current urology · 2022Article
- Intraoperative calculus or hemorrhage in transurethral seminal vesiculoscopy as a risk factor for recurrent hemospermia.PloS one · 2022Article
- Bothersome Hematospermia Following Stereotactic Body Radiation Therapy for Prostate Cancer.Frontiers in oncology · 2021Article
- Article
- Etiology of 305 cases of refractory hematospermia and therapeutic options by emerging endoscopic technology.Scientific reports · 2019Article
- Laboratory and clinical management of leukocytospermia and hematospermia: a review.Therapeutic advances in reproductive healthReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hematospermia is defined by the presence of blood in the semen typically occurring in men younger than 40 years of age. Symptoms can occur due to a multitude of reasons, but are usually benign and self-limiting, requiring no additional treatment or evaluation. Despite this, the condition often impairs quality of life due to associated anxiety and must be taken seriously by the patient and the physician, particularly if recurrent, refractory, and painful. The etiology of hematospermia can be classified into inflammatory, infectious, lithiasis, cystic, obstructive, tumoral, vascular, traumatic, iatrogenic, and systemic origin. Alternatively, it can also be divided into subcategories based on anatomical origins such as prostate, bladder, spermatic cord, seminal vesicles, or epididymis. A complete history and physician examination, laboratory testing, and a variety of invasive and non-invasive imaging and instrumentation modalities can help to identify and treat the underlying pathology promptly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.